Oncolytics SVP‑General Counsel Buys 1,660 Shares After FDA Fast‑Track Win—Insider Confidence Signals Possible Upswing
Oncolytics insider buy: SVP‑General Counsel Lee Chan Henry’s 2026 purchase after FDA Fast‑Track boosts confidence, shows disciplined strategy and potential upside.
3 minutes to read
